Experimental evidence to support ELITE

被引：32

作者：

Rump, LC ^{[1
]}

Oberhauser, V ^{[1
]}

Schwertfeger, E ^{[1
]}

Schollmeyer, P ^{[1
]}

机构：

[1] Univ Klin Freiburg, D-79106 Freiburg, Germany

来源：

LANCET | 1998年 / 351卷 / 9103期

关键词：

D O I：

10.1016/S0140-6736(05)78427-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：644 / 645

页数：2

共 5 条

[1] ROLE OF BRADYKININ IN THE CARDIAC EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS [J].

LINZ, W ;

SCHOLKENS, BA .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S83-S90

[2] Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) [J].

Pitt, B ;

Segal, R ;

Martinez, FA ;

Meurers, G ;

Cowley, AJ ;

Thomas, I ;

Deedwania, PC ;

Ney, DE ;

Snavely, DB ;

Chang, PI .

LANCET, 1997, 349 (9054) :747-752

[3] BETA(2)-ADRENERGIC RECEPTOR AND ANGIOTENSIN-II RECEPTOR MODULATION OF SYMPATHETIC NEUROTRANSMISSION IN HUMAN ATRIA [J].

RUMP, LC ;

SCHWERTFEGER, E ;

SCHAIBLE, U ;

FRAEDRICH, G ;

SCHOLLMEYER, P .

CIRCULATION RESEARCH, 1994, 74 (03) :434-440

[4] Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium [J].

Rump, LC ;

Berlit, T ;

Schwertfeger, E ;

Beyersdorf, F ;

Schollmeyer, P ;

Bohmann, C .

JOURNAL OF HYPERTENSION, 1997, 15 (11) :1263-1270

[5]

URATA H, 1990, J BIOL CHEM, V265, P22348

← 1 →